
|Articles|October 15, 2003
FDA OKs epikeratome device for Epi-LASIK
Atlanta-CIBA Vision Corp. will begin marketing its Centurion SES EpiEdge epikeratome for the Epi-LASIK refractive procedure this fall now that it has obtained U.S. regulatory approval.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
SpyGlass Pharma releases positive data from 2 trials of Bimatoprost Drug Pad-IOL System
2
Beyond the surface: Tackling complex dry eye cases
3
An Extreme Case of Demodex Blepharitis: From Misdiagnosis to Remarkable Recovery
4
Redefining glaucoma care: Where innovation meets clinical insight
5



















































.png)


